Continuous dopamine-receptor stimulation in advanced Parkinson's disease

被引:134
|
作者
Nutt, JG [1 ]
Obeso, JA
Stocchi, F
机构
[1] Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA
[2] Univ Navarra, Dept Neurol, E-31080 Pamplona, Spain
[3] Univ La Sapienza, Prima Clin Neurol, I-00185 Rome, Italy
关键词
D O I
10.1016/S1471-1931(00)00029-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Intermittent or pulsatile dopamine-receptor stimulation is postulated to induce plastic changes in motor systems that are responsible for the development of the motor fluctuations and dyskinesia that complicate long-term L-dopa therapy of Parkinson's disease. As a corollary to this hypothesis, continuous dopamine-receptor stimulation can avoid or reverse these complications. Such continuous stimulation is unlikely to mimic completely the normal function of the dopaminergic system, but should avoid the supra-physiological swings in extracellular dopamine that accompany intermittent L-dopa dosing. The concern is that this continuous stimulation might induce tolerance rather than sensitization to some effects of L-dopa. Open clinical trials support the value of continuous dopaminergic stimulation in Parkinson's disease with established motor complications, but rigorous studies, although experimentally difficult, are needed.
引用
收藏
页码:S109 / S115
页数:7
相关论文
共 50 条
  • [21] Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson's disease?
    Pirtosek, Z.
    Leta, V.
    Jenner, P.
    Verin, M.
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (11) : 1395 - 1404
  • [22] Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson’s disease?
    Z. Pirtošek
    V. Leta
    P. Jenner
    M. Vérin
    Journal of Neural Transmission, 2023, 130 : 1395 - 1404
  • [23] DOPAMINE-RECEPTOR SUBTYPES IN NEUROLOGICAL AND PSYCHIATRIC DISEASE
    CARLSSON, A
    PIERCEY, MF
    CLINICAL NEUROPHARMACOLOGY, 1995, 18 : S1 - S5
  • [24] SCHIZOPHRENIA AS A BRAIN DISEASE - THE DOPAMINE-RECEPTOR STORY
    SEEMAN, P
    ARCHIVES OF NEUROLOGY, 1993, 50 (10) : 1093 - 1095
  • [25] Dopamine receptor agonists for Parkinson's disease
    Blandini, Fabio
    Armentero, Marie-Therese
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (03) : 387 - 410
  • [26] Continuous dopaminergic stimulation in Parkinson's disease
    Silverdale, Monty
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2007, 11 (01) : 24 - 28
  • [27] ELECTROPHYSIOLOGICAL THALAMIC RESPONSES EVOKED BY DOPAMINE-RECEPTOR STIMULATION INTO THE STRIATUM
    PATINO, P
    GARCIAMUNOZ, M
    BRAIN RESEARCH, 1985, 361 (1-2) : 1 - 9
  • [28] EFFECTS OF DOPAMINE-RECEPTOR BLOCKADE ON SELF-STIMULATION IN MONKEY
    MORA, F
    ROLLS, ET
    BURTON, MJ
    SHAW, SG
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1976, 4 (02) : 211 - 216
  • [29] Dopamine-receptor antagonist
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (09) : 428 - 428
  • [30] DOPAMINE-RECEPTOR PHARMACOLOGY
    SEEMAN, P
    VANTOL, HHM
    CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY, 1993, 6 (04): : 602 - 608